智通财经APP获悉，正品控股有限公司(简称：正品控股)于2025年7月29日所递交的港股招股书满6个月，于2026年1月29日失效，递表时浤博资本有限公 司为其独家保荐人。 招股书显示，正品控股主要在香港从事保健及美容补充品与产品的开发、销售、营销及分销。集团将产品的生产外包给供货商(包括制造商)并主要通过 万宁在香港的零售门市以集团自有品牌及第三方品牌分销集团的产品。根据弗若斯特沙利文的资料，按2024年保健及美容补充品与产品的零售值计算， 集团于香港所有本地保健及美容补充品与产品供货商中排名第七，市场占有率约为1.6%。 | | 11/08/2025 整體協調人公告 - 委任（經修訂） PD | | --- | --- | | 29/07/2025 | 正品控股有限公司 29/07/2025 申請版本（第一次呈交） 全文檔案 [四] 多檔案 | ...

Core Viewpoint - The company is exploring potential opportunities for the independent listing of its telecommunications assets and businesses, as well as possible transactions involving its telecommunications assets in several European countries, although no decisions have been made yet [1]. Group 1 - The company announced on January 21 that it is aware of media reports regarding the potential independent listing of its global telecommunications assets and businesses, as well as transactions involving its telecommunications assets in certain European countries [1]. - The board has received suggestions and is evaluating opportunities to enhance long-term shareholder value, which includes the possibility of independent listings related to its assets and businesses [1]. - As of the announcement date, the board has not made any decisions regarding transactions involving the company's existing telecommunications or retail assets and businesses, including any independent listings [1]. Group 2 - The company's latest stock price is reported at HKD 61.35 per share, with a total market capitalization of HKD 235 billion [3].

Core Viewpoint - The company, CK Hutchison Holdings (00001), is reportedly considering a spin-off of its global telecommunications business, which includes operations in Europe, Hong Kong, and Southeast Asia, with potential listings in Hong Kong and London. However, the company has stated that no decisions have been made regarding this or any related transactions [1][2]. Group 1: Spin-off Plans - Recent media reports suggest that CK Hutchison is contemplating a spin-off of its global telecommunications business, potentially valuing the business at around $20 billion [1]. - The company has engaged with investment banks such as Goldman Sachs, Citigroup, and Deutsche Bank to explore the spin-off listing [1]. - CK Hutchison has clarified that it has not made any decisions regarding the independent listing of its telecommunications or retail assets [1]. Group 2: Internal Evaluations - There are indications that CK Hutchison is also evaluating a merger between its Italian telecommunications unit Wind Tre and Iliad's operations in Italy, which may lead to a pause in the spin-off plans [2]. - Internal discussions within CK Hutchison regarding the future direction of its global telecommunications business are reportedly divided, with a decision expected in the coming weeks [2].

Group 1 - The core announcement indicates that the company is exploring potential opportunities for the independent listing of its telecommunications assets and businesses, as well as possible transactions involving its telecommunications assets in several European countries [1] - The board has acknowledged media reports regarding the potential separation of the telecommunications business from its health and beauty products business, but no decisions have been made regarding any transactions or independent listings as of the announcement date [1] - The company emphasizes that there is currently no certainty regarding the execution of any such transactions, urging shareholders and potential investors to remain cautious [1]

Core Viewpoint - The company has achieved a gross margin of 75% and generates over 100 million in annual revenue from selling health and beauty products in Hong Kong, indicating strong market potential as it prepares for an IPO [1] Group 1 - The company specializes in health and beauty products, which have shown significant demand in the Hong Kong market [1] - The impressive gross margin of 75% highlights the company's effective cost management and pricing strategy [1] - Annual revenue exceeding 100 million demonstrates the company's established market presence and financial stability [1] Group 2 - The upcoming IPO reflects the company's growth ambitions and the potential for attracting further investment [1] - The health and beauty industry in Hong Kong is characterized by robust consumer spending, providing a favorable environment for the company's expansion [1] - The company's strong financial performance positions it well to capitalize on market opportunities post-IPO [1]

Core Viewpoint - 正品控股有限公司 is seeking to raise funds through an IPO to expand its market presence, open self-operated stores, enhance its sales network, and develop new products, while heavily relying on its largest customer, 牛奶有限公司 [1][6]. Financial Performance - The company reported revenues of HKD 43.193 million, HKD 109.618 million, and HKD 130.215 million for the fiscal years 2023, 2024, and 2025, respectively [3]. - Net profits for the same periods were HKD 11.313 million, HKD 35.483 million, and HKD 36.257 million [3]. - Gross profit margins are projected to decline from approximately 81.6% in 2023 to 75% in 2025 [4][5]. Market Position - 正品控股 ranks seventh among local suppliers of health and beauty supplements in Hong Kong, with a market share of about 1.6% [2]. - The company primarily sells its own and third-party branded health and beauty products through retail channels, particularly through 万宁 stores [2]. Customer Dependency - The company derives a significant portion of its revenue from its top five customers, with revenues of approximately HKD 39 million, HKD 98 million, and HKD 109 million for the fiscal years 2023, 2024, and 2025, respectively, accounting for about 90.6%, 89.4%, and 83.4% of total revenue [7]. - The largest customer, 牛奶有限公司, contributed approximately HKD 39 million, HKD 84 million, and HKD 97 million to total revenues for the same periods, representing about 89.1%, 76.7%, and 74.5% of total revenue [7]. Cost Structure - The cost of goods sold is expected to increase, with costs of HKD 7.952 million, HKD 23.432 million, and HKD 32.528 million for the fiscal years 2023, 2024, and 2025, respectively [3]. - Selling and distribution expenses are projected to rise from HKD 14.912 million in 2023 to HKD 36.435 million in 2025 [3].

Core Viewpoint - Zhengpin Holdings Limited has submitted its IPO application to the Hong Kong Stock Exchange, aiming to leverage its leading position in the health and beauty supplement market in Hong Kong, where it holds a market share of approximately 29.4% in 2024 [1][2]. Group 1: Company Overview - Zhengpin Holdings was established in 2011 and primarily operates in Hong Kong, focusing on health and beauty supplements and products [1]. - The company ranks first in the retail value of health-related supplements in Hong Kong for 2024, with a market share of about 29.4% [2]. - Zhengpin Holdings operates six proprietary brands and six third-party brands, with its own brand "Yantongxiao" being one of the top-selling products in Watsons [2]. Group 2: Business Model and Sales Channels - The company outsources product manufacturing to suppliers and primarily distributes products through Watsons in Hong Kong [2]. - Zhengpin Holdings has a mixed sales network that includes both wholesale and retail operations, with the majority of revenue coming from wholesale, accounting for approximately 89.7% to 93.0% during the reporting period [3]. Group 3: Financial Performance - The company reported revenues of approximately HKD 43 million, HKD 110 million, and HKD 130 million over the last three fiscal years, with a compound annual growth rate of about 73.6% [4]. - Net profits for the same periods were approximately HKD 11.3 million, HKD 35.5 million, and HKD 36.3 million [4]. - Gross profit margins have shown a declining trend, from approximately 81.6% to 75.0% over the reporting period [4]. Group 4: Customer and Supplier Concentration - The company relies heavily on a few key customers, with revenues from the top five customers accounting for about 90.6% to 83.4% of total revenue during the reporting period [5]. - Sales to the largest customer, Dairy Farm International Holdings, represented approximately 89.1% to 74.5% of total revenue [5]. - Supplier concentration is also high, with the top five suppliers accounting for about 86.3% to 77.3% of total procurement [5]. Group 5: Future Plans and Use of Proceeds - Zhengpin Holdings plans to use the funds raised from the IPO to expand its business in Taiwan, conduct strategic marketing in Hong Kong, open self-operated stores, and develop new product lines [8].

Core Viewpoint - 正品控股有限公司 has submitted an IPO application to the Hong Kong Stock Exchange, with a strong financial performance highlighted by a compound annual growth rate (CAGR) of 79% in net profit over the past three fiscal years and a gross margin of 75%, although over 70% of its revenue relies on a major client, "Milk Company" [1][2][6]. Financial Performance - The company achieved revenue of HKD 0.43 billion, HKD 1.10 billion, and HKD 1.30 billion for the fiscal years 2023, 2024, and 2025, respectively, with a CAGR of approximately 73.6% [3][4]. - Net profit attributable to shareholders for the same period was approximately HKD 11.31 million, HKD 35.48 million, and HKD 36.26 million, with a CAGR of about 79% [3][4]. - Significant growth was observed in fiscal year 2024, with revenue and net profit increasing by 155% and 214%, respectively, although growth is expected to slow in fiscal year 2025 [3][4]. Market Position - 正品控股 ranks seventh among local suppliers of health and beauty supplements in Hong Kong, with a market share of approximately 1.6% [2]. - The company holds the top position in the retail value of deer-related health supplements in Hong Kong, with a market share of about 29.4% [3]. Product Portfolio - The company offers a diverse product range catering to various demographics, focusing on niche markets such as deer-related health supplements, joint pain relief, and topical analgesics [2][3]. - 正品控股 operates six proprietary brands and six third-party brands, with proprietary brands including "正品," "炎痛消," and "Organicpharm" [2]. Sales Channels - The majority of the company's revenue comes from wholesale business, accounting for approximately 89.7%, 93.0%, and 88.8% of total revenue during the reporting period [6]. - Sales to the major client, "Milk Company," represented approximately 89.1%, 76.7%, and 74.5% of total revenue over the three fiscal years, indicating a high dependency on this client [6]. Future Plans - The company plans to use the funds raised from the IPO to expand its business in Taiwan, conduct strategic marketing and promotional activities in Hong Kong, open self-operated stores, and develop new product lines [7].

Core Insights - The company, Zhengpin Holdings, primarily engages in the development, sales, marketing, and distribution of health and beauty supplements and products in Hong Kong, outsourcing production to suppliers [3][4] - Zhengpin Holdings ranks seventh among local suppliers in Hong Kong's health and beauty supplement market with a market share of approximately 1.6% as of 2024 [3] - The company has a diverse product portfolio catering to various age groups and focuses on niche markets such as deer-related health supplements and pain relief products [3][4] Market Position - In the deer-related health supplement market, Zhengpin Holdings holds the top position with a market share of about 29.4% in 2024 [4] - The company's proprietary brand "Yantongxiao" is among the top five best-selling joint and pain relief supplements at Mannings retail stores [4] - Zhengpin Holdings operates six proprietary brands and six third-party brands, indicating a broad market presence [4] Financial Performance - The company reported revenues of approximately HKD 43.19 million, HKD 110 million, and HKD 130 million for the fiscal years 2023, 2024, and 2025, respectively [5][6] - Net profit and total comprehensive income for the same periods were approximately HKD 11.31 million, HKD 35.48 million, and HKD 36.26 million [5][6] - The gross profit margins for the fiscal years 2023 and 2024 were HKD 35.24 million and HKD 86.19 million, respectively, indicating a significant increase in profitability [6]